Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
2.070
-0.080 (-3.72%)
Aug 14, 2025, 2:51 PM - Market open

Ensysce Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
5113511418,673
Upgrade
Market Cap Growth
37.61%218.52%-30.67%-95.78%-99.39%21.62%
Upgrade
Enterprise Value
372911218,676
Upgrade
Last Close Price
2.158.1415.90135.0016920.0044764.92
Upgrade
PE Ratio
-----328929.48
Upgrade
PS Ratio
0.392.041.501.9132.284750.02
Upgrade
PB Ratio
1.523.14-5.12-1.19-13.97-2804.46
Upgrade
P/TBV Ratio
1.502.86----
Upgrade
EV/Sales Ratio
0.451.250.853.5531.664750.60
Upgrade
Debt / Equity Ratio
0.140.09-1.31-1.10-2.11-0.64
Upgrade
Asset Turnover
1.771.250.520.230.428.06
Upgrade
Quick Ratio
1.361.640.370.360.770.03
Upgrade
Current Ratio
2.102.420.690.560.950.05
Upgrade
Return on Equity (ROE)
-289.96%-585.41%----
Upgrade
Return on Assets (ROA)
-99.31%-101.29%-155.91%-135.76%-148.12%-206.67%
Upgrade
Return on Capital (ROIC)
-153.40%-216.54%-2204.12%-320.05%-372.49%-
Upgrade
Earnings Yield
-129.13%-75.19%-318.25%-502.55%-25.51%0.00%
Upgrade
Buyback Yield / Dilution
-284.17%-362.24%-1158.33%---
Upgrade
Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q